Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy

British Journal of Cancer

Volumn 73, Issue 3, 1996, Pages 288-293

  Van Geel, I P J ^a   Oppelaar, H ^a   Rijken, P F J W ^b   Bernsen, H J J A ^b   Hagemeier, N E M ^b   Van Der Kogel, A J ^b   Hodgkiss, R J ^c   Stewart, F A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c Gray Laboratory   (United Kingdom)

Author keywords

Hypoxia; Image analysis; Photodynamic therapy; Photofrin; RIF 1; Vascular perfusion

Indexed keywords

FLUORESCENT DYE; HOE 33342; PHOTOFRIN; RUBIDIUM 86;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CANCER THERAPY; CONTROLLED STUDY; FEMALE; HYPOXEMIA; IMAGE ANALYSIS; MOUSE; NONHUMAN; PERFUSION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR; TUMOR VASCULARIZATION;

EID: 0030043020     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.51     Document Type: Article

References (33)

1. BAAS P, OPPELAAR H, STAVENUITER M, ZANDWIJK N AND STEWART FA. (1993). Interaction of the bioreductive drug (SR4233) and photodynamic therapy using Photofrin II in a mouse tumour model. Int. J. Radiat. Biol. Oncol. Phys., 27, 665-670.
2. BAAS P, OPPELAAR H, MICHIELSEN C, ZANDWIJK N AND STEWART FA. (1994). Enhancement of interstitial photodynamic therapy by Mitomycin C and EO9 in a mouse tumour model. Int. J. Cancer, 56, 880-885.
3. BEGG AC, HODGKISS RJ, MCNALLY NJ, MIDDLETON RW, STRATFORD MRL AND TERRY NHA. (1985). Fluorescent markers for hypoxic cells: a comparison of two compounds on three cell lines. Br. J. Radiol., 58, 645-654.
4. BERNSEN HJJA, RIJKEN PFJW, OOSTENDORP T AND VAN DER KOGEL AJ. (1995). Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. Br. J. Cancer, 71, 721-726.
5. BREMNER JCM, ADAMS GE, PEARSON JK, SANSOM J, STRATFORD IJ, BEDWELL J, BOWN SG AND PHILIPS D. (1992). Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145. Br. J. Cancer, 66, 1070-1076.
6. CHAPLIN DJ AND ACKER B. (1987). The effect of hydralazine on the tumour cytotoxicity of the hypoxic cell cytotoxin RSU-1069; evidence for therapeutic gain. Int. J. Radiat. Oncol. Biol. Phys., 13, 579-585.
7. CHAPLIN DJ, OLIVE PL AND DURAND RE. (1987). Intermittent blood flow in a murine tumour: radiobiological effects. Cancer Res., 47, 597-601.
8. CHAPMAN JD, STOBBE CC, ARNFIELD MR, SANTUS R, LEE J AND MCPHEE MS. (1991a). Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. Radiat. Res., 126, 73-79.
9. CHAPMAN JD, MCPHEE MS, WALZ N, CHETNER MP, STOBBE CC, SODERLIND K, ARNFIELD M, MEEKER BE, TRIMBLE L AND ALLEN PS. (1991b). Nuclear magentic resonance spectroscopy and sensitizer adduct measurements of photodynamic therapy induce ischemia in solid tumors. J. Natl Cancer Inst., 22, 1650-1659.
10. COCO-MARTIN JM, BRUNINK F, VELDEN-DE GROOT TAM AND COEN BEUVERY E. (1992). Analysis of glycoforms present in two mouse IgG2a monoclonal antibody preparations. J. Immunol. Methods, 155, 241-248.
11. FOLKMAN J. (1993). Tumour angiogenesis. In Cancer Medicine 3rd edn, Holland J, Frei E, Bast RC, Kufe DW, Morton DL and Weichselbaum RR (eds). pp. 153-170. Lea & Febiger: Philadelphia.
12. FOSTER TH, MURANT RS, BRYANT RG, KNOX RS, GIBSON SL AND HILF R. (1991). Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res., 126, 296-303.
13. GONZALEZ S, ARNFIELD MR, MEEKER BE, TULIP J, LAKEY WH AND CHAPMAN JD. (1986). Treatment of Dunning R3327-AT rat prostate tumours with photodynamic therapy in combination with misonidazole. Cancer Res., 46, 2858-2862.
14. HALL EJ. (1994). Radiobiology for the Radiobiologists, 4th edn pp. 133-152, JB Lippincott: Philadelphia.
15. HENDERSON BW AND FINGAR VH. (1987). Relationship of tumour hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res., 47, 3110-3114.
16. HENDERSON BW, WALDOW SM, MANG TS, POTTER WR, MALONE PB AND DOUGHERTY TJ. (1985). Tumour destruction and kinetics of tumour cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res., 45, 572-576.
17. HIRSCH BD, WALZ NC, MEEKER BE, ARNFIELD MR, TULIP J, MCPHEE MS AND CHAPMAN JD. (1987). Photodynamic therapy-induced hypoxia in rat tumors and normal tissues. Photochem. Photobiol., 46, 847-852.
18. HODGKISS RJ, JONES G, LONG A, PARRICK J, SMITH KA, STRATFORD MRL AND WILSON GD. (1991). Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br. J. Cancer, 63, 119-125.
19. KOCH CJ. (1993). Unusual oxygen concentration dependence of toxicity of SR4233, a hypoxic cell toxin. Cancer Res., 53, 3992-3997.
20. MARSHALL RS AND RAUTH M. (1986). Modification of the cytotoxic activity of mitomycin c by oxygen and ascorbic acid in chinese hamster ovary cells and a repair-deficient mutant. Cancer Res., 46, 2709-2713.
21. MOORE RB, CHAPMAN JD, MERCER JR, MANNAN RZ, WIEBE LI, MCEWAN AJ AND MCPHEE MS. (1993). Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123 iodoazomycin arabinoside. J. Nucl. Med., 34, 405-411.
22. MULCAHY RT. (1984). Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro. Cancer Res., 44, 4409-4413.
23. RIJKEN PFJW, BERNSEN HJJA AND VAN DER KOGEL AJ. (1995). Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvascular Res., 50.
24. STAR WM, MARIJNISSEN HPA, BERG-BLOK AE, VERSTEEG JAC, FRANKEN KAP AND REINHOLD HS. (1986). Destruction of rat mammary tumour and normal tissue microcirculation by hematoporphyrin derivative photoirradiation observed in vivo in sandwich observation chambers. Cancer Res., 46, 2532-2540.
25. TAYLOR YC AND RAUTH AM. (1982). Oxygen tension, cellular respiration, and redox state as variables influencing the cytotoxicity of the radiosensitizer misonidazole. Radiat. Res., 91, 104-123.
26. THOMLINSON RH AND GRAY LH. (1955). The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer, 9, 539-549.
27. TROTTER MJ, CHAPLIN DJ, DURAND RE AND OLIVE PL. (1989). The use of fluorescent probes to identify regions of transient perfusion in murine tumors. Int. J. Radiat. Oncol. Biol. Phys., 16, 931-934.
28. TROTTER MJ, OLIVE PL AND CHAPLIN DJ. (1990). Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse. Br. J. Cancer, 62, 903-908.
29. TWENTYMAN PR, BROWN JM, GRAY JW, FRANKA AJ, SCOLES MA AND KALLMAN RF. (1980). A new mouse tumour model system (RIF-1) for comparison of end-point studies. J. Natl Cancer Inst., 64, 594-604.
30. VAUPEL P, KALLINOWSKI F AND OKUNIEFF P. (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res., 49, 6449-6463.
31. VAN GEEL IPJ, OPPELAAR H, OUSSOREN Y AND STEWART FA. (1994). Changes in perfusion of mouse tumours after photodynamic therapy. Int. J. Cancer, 56, 224-228.
32. VAN GEEL IPJ, OPPELAAR H, OUSSOREN Y, SCHUITMAKER JJ AND STEWART FA. (1995a). Mechanisms for optimising PDT: second generation photosensitizers in combination with mitomycin C. Br. J. Cancer, 72, 344-350.
33. VAN GEEL IPJ, OPPELAAR H, OUSSOREN Y AND STEWART FA (1995b). Photosensitizing efficacy of mTHPC-PDT compared to Photofrin-PDT in the RIF-1 tumour and normal skin. Int. J. Cancer, 60, 388-394.